Nu Skin Enterprises, Inc. (NUS) News

Nu Skin Enterprises, Inc. (NUS): $41.07

-0.35 (-0.85%)

POWR Rating

Component Grades













Filter NUS News Items

NUS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NUS News Highlights

  • For NUS, its 30 day story count is now at 12.
  • Over the past 14 days, the trend for NUS's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • SKIN, ACT and BAND are the most mentioned tickers in articles about NUS.

Latest NUS News From Around the Web

Below are the latest news stories about Nu Skin Enterprises Inc that investors may wish to consider to help them evaluate NUS as an investment opportunity.

New Strong Sell Stocks for October 18th

CNFR, RACE, GGG, NUS, and LRN have been added to the Zacks Rank #5 (Strong Sell) List on October 18, 2021.

Yahoo | October 18, 2021

Rhyz Analytical Labs Launches Analytical Testing Services for Beauty and Wellness Companies

Rhyz Analytical Labs today announced the availability of its testing services for beauty and wellness companies to assess product safety and effectiveness through trusted, timely and accurate results. Rhyz Analytical Labs combines the knowledge of a team of experienced scientists across multiple disciplines with the latest technology and equipment to quickly and thoroughly address any testing requirements for foods, dietary supplements and cosmetic products.

Yahoo | October 13, 2021

Why The 22% Return On Capital At Nu Skin Enterprises (NYSE:NUS) Should Have Your Attention

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Yahoo | October 13, 2021

Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt

Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.

Yahoo | October 13, 2021

Infant Dietary Supplements Market SWOT Analysis till 2027 Players are Amway, Abbott, Arkopharma, Bayer AG, Glanbia plc, Pfizer Inc., ADM, Carlyle Investment Management L.L.C., Nu Skin Enterprises, GlaxoSmithKline Consumer Healthcare

Infant dietary supplements market is expected to grow at a rate of 14.0% in the forecast period 2020 to 2027. Increasing health awareness among the people will act as a factor for the infant dietary supplements market in the forecast

OpenPR | October 11, 2021

D.A. Davidson Stick to Their Hold Rating for Nu Skin Enterprises By

D.A. Davidson Stick to Their Hold Rating for Nu Skin Enterprises | October 6, 2021

Nu Skin Enterprises Insider Trades $130K In Company Stock

Jeffrey Bettinger, SVP And People Places Officer at Nu Skin Enterprises (NYSE:NUS), made a large insider sell on October 5, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Bettinger sold 3,123 shares of Nu Skin Enterprises at prices ranging from $41.10 to $41.48. The total transaction amounted to $128,925. Following the transaction, Bettinger still owns 16,068 shares of Nu Skin Enterprises worth $648,343. Nu Sk

Yahoo | October 6, 2021

Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles

Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.

Yahoo | October 5, 2021

Nu Skin Enterprises Provides Estimated Third Quarter Revenue

PROVO, Utah , Oct. 4, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS ) today announced estimated third quarter revenue between $637 and $642 million . "Our third quarter revenue was softer than anticipated as the delta variant created unexpected disruptions in many of our markets," said Ryan Napierski , president and CEO of Nu Skin. "Unanticipated government restrictions impacted our ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia , and also disrupted promotional activities such as incentive trips and the performance of local expos in several markets. "Despite the unanticipated COVID-related disruptions, our Collagen+ launch in the U.S. drove continued strong growth, and we successfully introduced our Tencent digital tools...

Benzinga | October 4, 2021

7 Low Price-to-Sales Stocks for Value-Focused Investors

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like SIG, GIII, NUS, MET, MT, MOS and HIBB are promising picks.

Yahoo | October 4, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7322 seconds.